Scientific work

Prof. Dr. Leylagül Kaynar

572 publications. The source of the information is stated next to each publication.

Back to profile
  1. Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease

    Springer eBooks, 2024

    DOI 10.1007/978-3-031-74081-7_21 Source: OpenAlex

  2. Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

    Frontiers in Immunology, 2023

    DOI 10.3389/fimmu.2023.1276295 PMID 37901215 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

    Annals of Hematology, 2023

    DOI 10.1007/s00277-023-05216-3 PMID 37067556 12 citations (Europe PMC) Source: OpenAlex

  4. The effect of danger-associated molecular patterns on survival in acute graft versus host disease

    Bone Marrow Transplantation, 2023

    DOI 10.1038/s41409-023-02145-7 PMID 37935781 3 citations (Europe PMC) Source: OpenAlex

  5. Protective role of olive oil extract of propolis on short and long‐term administration of tamoxifen in rats

    Environmental Toxicology, 2023

    DOI 10.1002/tox.24091 PMID 38108573 1 citation (Europe PMC) Source: OpenAlex

  6. REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS

    Hematological Oncology, 2023

    DOI 10.1002/hon.3164_301 Source: OpenAlex

  7. Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

    Transfusion and Apheresis Science, 2023

    DOI 10.1016/j.transci.2023.103809 PMID 37690861 2 citations (Europe PMC) Source: OpenAlex

  8. Determination of Genotypes in Cytomegalovirus (CMV) Strains Obtained from Pediatric and Adult Immunocompromised Patients

    Journal of Basic and Clinical Health Sciences, 2023

    DOI 10.30621/jbachs.1095228 Source: OpenAlex

  9. Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse

    Medical Records, 2023

    DOI 10.37990/medr.1259944 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study

    Transfusion and Apheresis Science, 2023

    DOI 10.1016/j.transci.2023.103838 PMID 37925340 1 citation (Europe PMC) Source: OpenAlex

  11. Adult Onset Langerhans Cell Histiocytosis: A Single Center Experience

    Medical Records, 2023

    DOI 10.37990/medr.1159055 Open-access full textSource: OpenAlex

  12. Evaluation Of Refeeding Hypophosphatemia Frequency, Risk Factors And Nutritional Status During Stem Cell Transplantation In Patients With Hematologic Malignancy

    Clinical Nutrition ESPEN, 2023

    DOI 10.1016/j.clnesp.2022.09.149 Source: OpenAlex

  13. A retrospective analysis on mucormycosis in patients with hematological diseases: a single center experience from Turkey

    Journal of Health Sciences and Medicine, 2023

    DOI 10.32322/jhsm.1262880 Source: OpenAlex

  14. Donor cell leukemia after allogeneic hematopoietic stem cell transplantation: a case report

    Journal of Current Hematology & Oncology Research, 2023

    DOI 10.51271/jchor-0011 Source: OpenAlex

  15. P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000971608.25225.83 Source: OpenAlex

  16. POSTER: AML-146 The Tip of the Iceberg: Vaginal Bleeding and Granulocytic Sarcoma of the Uterus

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)00502-5 Source: OpenAlex

  17. AML-146 The Tip of the Iceberg: Vaginal Bleeding and Granulocytic Sarcoma of the Uterus

    Clinical Lymphoma Myeloma & Leukemia, 2023

    DOI 10.1016/s2152-2650(23)01005-4 Source: OpenAlex

  18. A rare case of acute basophilic leukemia

    Journal of Current Hematology & Oncology Research, 2023

    DOI 10.51271/jchor-0016 Source: OpenAlex

  19. Prospective Evaluation of Critically İll Patients with Therapeutic Plasma Exchange in Medical İntensive Care Unit

    Eurasian Journal of Critical Care, 2023

    DOI 10.55994/ejcc.1385367 Source: OpenAlex

  20. Hereditary hyperferritinemia cataract syndrome with iron deficiency : a case report

    Journal of Current Hematology & Oncology Research, 2023

    DOI 10.51271/jchor-0024 Source: OpenAlex

  21. The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy

    Emergency Medicine International, 2022

    DOI 10.1155/2022/9222379 PMID 35784641 23 citations (Europe PMC) Open-access full textSource: OpenAlex

  22. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-05052-x PMID 36401621 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  23. Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors

    Infection and Chemotherapy, 2022

    DOI 10.3947/ic.2022.0005 PMID 36047301 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  24. Evaluation of refeeding hypophosphatemia frequency, risk factors, and nutritional status during stem cell transplantation in patients with hematologic malignancy

    Clinical Nutrition ESPEN, 2022

    DOI 10.1016/j.clnesp.2022.07.014 PMID 36184232 3 citations (Europe PMC) Source: OpenAlex

  25. Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)

    Transfusion and Apheresis Science, 2022

    DOI 10.1016/j.transci.2022.103373 PMID 35123893 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  26. Eltrombopag for Treatment of Thrombocytopenia After Hematopoietic Stem Cell Transplantation

    Turkish Journal of Hematology, 2022

    DOI 10.4274/tjh.galenos.2022.2021.0675 PMID 35297243 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  27. Evaluation of COVID‐19 fear and quality of life in patients with haematopoietic stem cell transplantation during the COVID‐19 pandemic

    European Journal of Cancer Care, 2022

    DOI 10.1111/ecc.13604 PMID 35502925 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  28. Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

    Blood, 2022

    DOI 10.1182/blood-2022-168558 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00523-6 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  30. Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): the Turkish hematology research and education group (ThREG)-TMA02 study

    Transfusion and Apheresis Science, 2022

    DOI 10.1016/j.transci.2022.103365 PMID 35120823 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  31. P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000847780.61937.3d Source: OpenAlex

  32. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation

    Indian Journal of Hematology and Blood Transfusion, 2022

    DOI 10.1007/s12288-022-01575-5 PMID 37006979 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  33. Antibody Response against Vaccine Antigens in Children after TCRαβ-Depleted Haploidentical Stem Cell Transplantation: Is It Similar to That in Recipients with Fully Matched Donors?

    Transplantation and Cellular Therapy, 2022

    DOI 10.1016/j.jtct.2022.10.019 PMID 36323399 1 citation (Europe PMC) Source: OpenAlex

  34. Comparison of ATRA-Arsenic Trioxide and ATRAIdarubicin in Patients with Acute Promyelocytic Leukemia

    LLM Dergi, 2022

    DOI 10.5578/llm.20229703 Source: OpenAlex

  35. P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000847772.34235.05 Open-access full textSource: OpenAlex

  36. P-278: Post-authorization safety of lenalidomide + dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey

    Clinical Lymphoma Myeloma & Leukemia, 2022

    DOI 10.1016/s2152-2650(22)00608-5 Source: OpenAlex

  37. Otolog Kök Hücre Transplantasyonunda Sitomegalovirüs (CMV) ve Hepatit B (HBV) Reaktivasyonu: Tek Merkez Deneyimi

    LLM Dergi, 2022

    DOI 10.5578/llm.20229802 Open-access full textSource: OpenAlex

  38. EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC

    Hematology Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1213 Source: OpenAlex

  39. Inherited transmission of the CSF3R T618I mutation: a familial report

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-05050-z PMID 36376598 Source: OpenAlex

  40. Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era

    Blood, 2022

    DOI 10.1182/blood-2022-168627 Source: OpenAlex

  41. The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

    DOI 10.3906/sag-2007-228 PMID 33517607 23 citations (Europe PMC) Open-access full textSource: OpenAlex

  42. Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

    Hematological Oncology, 2021

    DOI 10.1002/hon.2897 PMID 34171130 15 citations (Europe PMC) Source: OpenAlex

  43. Efficacy of therapeutic plasma exchange in patients with Crimean‐Congo hemorrhagic fever

    Journal of Clinical Apheresis, 2021

    DOI 10.1002/jca.21875 PMID 33485278 4 citations (Europe PMC) Source: OpenAlex

  44. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  45. Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or Without Aplastic Anemia: Multicenter Turkish Experience

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0105 PMID 34057336 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  46. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy

    Indian Journal of Hematology and Blood Transfusion, 2021

    DOI 10.1007/s12288-021-01466-1 PMID 35496952 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  47. RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES

    Hematological Oncology, 2021

    DOI 10.1002/hon.76_2880 Source: OpenAlex

  48. The Effect of Blood Groups on Infection and Prognosis of SARS-CoV-2

    Medical Records, 2021

    DOI 10.37990/medr.896945 Source: OpenAlex

  49. Evaluation of Epileptic Seizures Developed During Hematopoietic Stem Cell Transplantation: A Single Center Experience

    Acta Oncologica Turcica, 2021

    DOI 10.5505/aot.2021.57805 Open-access full textSource: OpenAlex

  50. HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/s2152-2650(21)01845-0 Source: OpenAlex